Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients (Q73906486)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1997

Language	Label	Description	Also known as
English	Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients	scientific article published on 01 October 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

based on heuristic

inferred from title

Jose Lopez-Miranda

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Francisco Perez-jimenez

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Francisco Perez-jimenez

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

J L Zambrana

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Velasco

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Castro

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Concha

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Vallés

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Montilla

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J A Jimenéz-Perepérez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

80

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

836-840

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Treatment of hyperlipidemia in heart transplant recipients with gemfibrozil +/- lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Hemostatic changes in heart transplant recipients and their relationship to accelerated coronary sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Metabolic risk factors for atherosclerosis in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Lovastatin does not affect oral glucose tolerance in hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900532-8

7 January 2021

Identifiers

10.1016/S0002-9149(97)00532-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9381994%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73906486&oldid=2048048279"